Work

Phase I/II study of BSK01, an artificial intelligence-driven, peptide-pulsed, mature DC immunotherapy for solid and hematological malignancies.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.tps3136

Authors: Leonardo Mirandola, Zahra Timsah, Diane Duyen Thuy Nguyen, Robert Bresalier, Naval Guastad Daver, Maurizio Chiriva-Internati

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889918346

Cites:

Cited by: 1

Related to: 10